Please assess the completion status of the following clinical trial:

Trial Title: L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with acute ruptures of the ACL who are willing to undergo treatment within 18 weeks of injury~Exclusion Criteria:~* Prior ACL reconstruction or other surgical procedure on the affected (target) knee~* Chronic ACL injury; interventional surgery scheduled 127 days or more after ACL injury~* Professional athletes currently engaged in active sport~* Prior distal femoral and/or proximal tibial fracture(s) of the target leg~* Previous or current ACL injury on contra-lateral leg~* Multi-ligament reconstruction~* Malalignment or varus thrust~* Patient \> 193 cm tall (6' 4)~* The patient does not follow pre-operative rehabilitation that may have been prescribed post-injury (prior to Index Procedure)~* Confirmed connective tissue disorder~* Signs of moderate to severe degenerative joint disease~* Severe pain, swelling, or redness within 24 hours prior to surgery~* Complete or partial Posterior Cruciate Ligament (PCL) tear~* If concomitant meniscal injury is present, any of the following: 1/3rd meniscal resection; complex double-bucket tear; partially repaired meniscal tears~* Any type of lateral and/or medial meniscal tear which is not repairable (\<2mm from rim)~* Additional concomitant injuries to the knee or lower extremities requiring treatment, per surgeon's discretion, that are not allowable under the Inclusion criteria~* The patient is unwilling to not participate in sporting activities for at least 9 months post-procedure~* The patient is mentally compromised~* The patient has a neuromuscular disorder that would engender unacceptable risk of knee instability, prosthesis fixation failure, or complications in postoperative care~* The patient has an active or latent infection in or about the affected knee joint or an infection site distant from the knee that may spread to the knee hematogenously~* Pregnant based on a positive beta hCG serum or an in vitro diagnostic test result or breast-feeding~* The patient is obese with a BMI \> 35~* The patient has a known allergy to PLLA~* The patient has a medical condition or comorbidity that would interfere with study participation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- L-C Ligament (Type: EXPERIMENTAL): Soft Tissue Regeneration's L-C Ligament is an investigation, interventional device intended for ACL reconstruction surgery within 18 weeks of acute rupture of the ACL and no previous surgical treatment. The L-C Ligament temporarily replaces the human anterior cruciate ligament (ACL) and provides a bioresorbable scaffold within and around which the native ACL will regenerate over time.
- Hamstring Autograft (Type: ACTIVE_COMPARATOR): Hamstring autograft is the active comparator for this study. Autograft tissue is the gold-standard treatment for primary ACL reconstruction.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy